Cloning and initial characterization of the human DPYD gene promoter

Biochemical and Biophysical Research Communications

Volumn 271, Issue 1, 2000, Pages 28-35

  Collie Duguid, E S R ^a,c   Johnston, S J ^a   Powrie, R H ^a   Milano, G ^b   Etienne, M C ^b   Rochat, B ^a   Watson, G C ^a   McLeod, H L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

5 Fluorouracil; Cynomolgus; Dihydropyrimidine dehydrogenase; Human; Polymorphism; Promoter; Rhesus; Toxicity; Transcription

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; GAMMA INTERFERON; PYRIMIDINE;

ARTICLE; CANCER; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA DEGRADATION; DNA FLANKING REGION; DNA POLYMORPHISM; DRUG METABOLISM; DRUG TOXICITY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MONKEY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY;

MACACA FASCICULARIS; PRIMATES;

EID: 0034728795     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2593     Document Type: Article

References (35)

1. Lu, Z. H., Zhang, R. W., and Diasio, R. B. (1992) J. Biol. Chem. 267, 17102-17109.
2. Heggie, G. D., Sommadossi, J. P., Cross, D. S., Huster, W. J., and Diasio, R. B. (1987) Cancer Res. 47, 2203-2206.
3. Grem, J. L. (1996) in Cancer Chemotherapy and Biotherapy: Principles and Practice (Chabner, B., and Longo, D. L., Eds.), 2nd ed., pp. 149-212. Lippincott, Philadelphia, PA.
4. Etienne, M. C., Lagrange, J. L., Dassonville, O., Fleming, R., Thyss, A., Renee, N., Schneider, M., Demard, F., and Milano, G. (1994) J. Clin. Oncol. 12, 2248-2253.
5. Gonzalez, F. J., and Fernandez-Salguero, P. (1995) Trends Pharmacol. Sci. 16, 325-327.
6. McMurrough, J., and McLeod, H. L. (1996) Br. J. Clin. Pharmacol. 41, 425-427.
7. van Gennip, A. H., Abeling, N. G. G. M., Vreken, P., and van Kuilenburg, A. B. P. (1997) J. Inher. Metab. Dis. 20, 203-213.
8. McLeod, H. L., Collie-Duguid, E. S. R., Vreken, P., Johnson, M. R., Wei, X., Sapone, A., Diasio, R. B., Fernandez-Salguero, P., van Kuilenburg, A. B. P., van Gennip, A. H., and Gonzalez, F. J. (1998) Pharmacogenetics 8, 455-459.
9. Collie-Duguid, E. S. R., Etienne, M. C., Milano, G., and McLeod, H. L. (2000) Pharmacogenetics 10, 217-223.
10. Wei, X. X., McLeod, H. L., McMurrough, J., Gonzalez, F. J., and Fernandez-Salguero, P. (1996) J. Clin. Invest. 98, 610-615.
11. Kouwaki, M., Hamajima, N., Sumi, S., Nonaka, M., Sasaki, M., Dobashi, K., Kidouchi, K., Togari, H., and Wada, Y. (1998) Clin. Cancer Res. 4, 2999-3004.
12. van Kuilenburg, A. B. P., Vreken, P., Abeling, N. G. G. M., Bakker, H. D., Meinsma, R., van Lenthe, H., de Abreu, R. A., Smeitink, J. A. M., et al. (1999) Human Genet. 104, 1-9.
13. Fujimoto, S., Matsuda, K., Kikugawa, M., Kaneko, M., and Tamaki, N. (1991) J. Nutr. Sci. Vit. 37, 89-98.
14. McLeod, H. L., Sludden, J., Hardy, S. C., Lock, R. E., Hawksworth, G. M., and Cassidy, J. (1998) Eur. J. Cancer. 34, 1623-1627.
15. Ho, D. H., Townsend, L., Luna, M. A., and Bodey, G. P. (1986) Anticancer Res. 6, 781-784.
16. Johnston, S. J., Ridge, S. A., Cassidy, J., and McLeod H. L. (1999) Clin. Cancer Res. 5, 2566-2570.
17. Ishikawa, Y., Kubota, T., Otani, Y., Watanabe, M., Teramoto, T., Kumai, K., Kitajima, M., Takechi, T., Okabe, H., and Fukushima, M. (1999) Clin. Cancer Res. 5, 883-889.
18. McLeod, H. L., Sludden, J., Murray, G. I., Keenan, R. A., Davidson, A. I., Park, K., Koruth, M., and Cassidy, J. (1998) Br. J. Cancer 77, 461-465.
19. Milano, G., Etienne, M. C., Pierrefite, V., Barberi-Heyob, M., Deporte-Fety, R., and Renee, N. (1999) Br. J. Cancer 79, 627-630.
20. Cormack, R. S., and Somssich, I. E. (1997) Gene 194, 273-276.
21. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254.
22. Wei, X., Elizondo, G., Sapone, A., McLeod, H. L., Raunio, H., Fernandez-Salguero, P., and Gonzalez, F. J. (1998) Genomics 51, 391-400, doi:10.1006/geno.1998.5379.
23. Drewes, T., Kleinhitpass, L., and Ryffel, G. U. (1991) Nucleic Acid Res. 19, 6383-6389.
24. Graves, B. J., and Petersen, J. M. (1998) Adv. Cancer Res. 75, 1-55.
25. Kass, S. U., Pruss, D., and Wolffe, A. P. (1997) Trends Genet. 13, 444-449.
26. Weis, L., and Reinberg, D. (1992) FASEB J. 6, 3300-3309.
27. Geng, Y., and Johnson, L. F. (1993) Mol. Cell Biol. 13, 4894-4903.
28. Speek, M., Barry, F., and Miller, W. L. (1996) Human Mol. Genet. 5, 1749-1758.
29. Fernandez-Salguero, P. M., Sapone, A., Wei, X., Holt, J. R., Jones, S., Idle, J. R., and Gonzalez, F. J. (1997) Pharmacogenetics 7, 161-163.
30. Holopainen, I., Pulkki, K., Heinonen, O. J., Nanto-Salonen, K., Haataja, L., Greter, J., Holme, E., van Kuilenburg, A. B. P., Vreken, P., and van Gennip, A. H. (1997) J. Inher. Metab. Dis. 20, 719-720.
31. Hayashi, Y., Wang, W., Ninomiya, T., Nagano, H., Ohta, K., and Itoh, H. (1999) J. Clin. Pathol. Mol. Pathol. 52, 19-24.
32. van Kuilenburg, A. B. P., van Lenthe, H., Blom, M. J., Mul, E. P. J., and van Gennip, A. H. (1999) Br. J. Cancer. 79, 620-626.
33. Ismail, A., van Groeningen, C. J., Hardcastle, A., Ren, Q., Aherne, G. W., Geoffroy, F., Allegra, C. J., and Grem, J. L. (1998) Mol. Pharmacol. 53, 252-261.
34. Milano, G., Fischel, J-L., Etienne, M-C., Renee, N., Formento, P., Thyss, A., Gaspard, M-H., Thill, L., and Cupissol, D. (1994) Cancer Chemother. Pharmacol. 34, 147-152.
35. Yee, L. K., Allegra, C. J., Steinberg, S. M., and Grem, J. L. (1992) J. Natl. Cancer Inst. 84, 1820-1825.